Abstract
Animal dander is a common cause of allergic rhinitis and allergic asthma in patients. In this regard, cats and dogs represent major causes of allergy to animal dander. In first line, the therapeutic options include the elimination of the pet from the patient's home as a (secondary) preventive step. However, avoidance of temporary contacts or indirect exposure to cat dander is often difficult, since cat-allergens are widely distributed even in non-cat-keeping households. In general, conventional pharmacologic therapy does not thoroughly prevent allergic symptoms. Therefore, allergen-specific immunotherapy (SIT) represents an important therapeutic option. This article highlights the current standards and further developments of SIT for cat-allergic patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
